Maharashtra and Kerala account for 71.69% of India’s Active Cases

Maharashtra, Kerala, Punjab, Karnataka, Gujarat and Tamil Nadu continue to report a surge in the COVID daily cases and they cumulatively account for 85.6% of the new cases reported in the past 24 hours, according to Union Health Ministry. In the last 24 hours 23,285 new cases were registered. Maharashtra has reported the highest daily new cases at 14,317 (61.48% of the daily new cases). It is followed by Kerala with 2,133 while Punjab reported 1,305 new cases.

India’s total Active Caseload has reached 1,97,237 today and present active caseload now stands at 1.74% of India’s total Positive Cases. Five states cumulatively account for 82.96% of the total active cases in the country. Two states – Maharashtra and Kerala- account for 71.69% of India’s total active cases.

Meanwhile, the Centre is actively engaging with all State and UT governments, especially those showing an upsurge in daily new cases and with a high caseload of active cases. The Union Government is regularly reviewing the status of COVID containment and public health measures with them. Recently, the Centre rushed high level Public Health teams to Maharashtra and Punjab to assist in COVID-19 control and containment measures in view of recent spike in cases in these States. The Central Government had earlier also deputed high-level teams to Maharashtra, Kerala, Chhattisgarh, Madhya Pradesh, Gujarat, Punjab, Karnataka, Tamil Nadu, West Bengal, and Jammu and Kashmir to support them in their fight against the recent spike in COVID-19 cases. The reports of Central Teams are shared with the States for further follow up action. The follow up and compliance on part of states is monitored by the Union Ministry of Health.

More than 2.61 crore vaccine doses have been administered through 4,87,919 sessions, as per the provisional report till 7 am today. These include 72,23,071 HCWs (1st dose), 40,56,285 HCWs (2nd dose), 71,21,124 FLWs (1st dose) and 6,72,794 FLWs (2nd Dose), 10,30,612 beneficiaries aged more than 45 years with specific co-morbidities (1st Dose) and 60,61,034 beneficiaries aged more than 60 years.